BATS BZX Real-Time Price
As of 12:43pm ET
| -0.08 / -0.31%|
The 5 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +16.96% increase from the last price of 25.65.
The current consensus among 5 polled investment analysts is to Hold stock in NxStage Medical Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.